Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Estéfano Pinilla

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|December 11, 2020
Transglutaminase 2 as a novel target in chronic kidney disease - Methods, mechanisms and pharmacological inhibitionJudit Prat-Duran, Estéfano Pinilla, Rikke Nørregaard, et al.
International Journal of Molecular Sciences|May 13, 2023
Sex-Dependent Impairment of Endothelium-Dependent Relaxation in Aorta of Mice with Overexpression of Hyaluronan in Tunica MediaKaren Axelgaard Lorentzen, Raquel Hernanz, Estéfano Pinilla, et al.
The Journal of Sexual Medicine|March 24, 2022
Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db MiceSimon Comerma-Steffensen, Judit Prat-Duran, Susie Mogensen, et al.
The Journal of Sexual Medicine|April 14, 2023
Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db MiceSimon Comerma-Steffensen, Judit Prat-Duran, Susie Mogensen, et al.
International Journal of Molecular Sciences|June 26, 2025
Renal and Vascular Effects of the Allosteric Transglutaminase 2 Modulator LDN-27219 in One-Kidney DOCA-Salt MiceIan Mees, Judit Prat-Duran, Simon Comerma-Steffensen, et al.
Life Sciences|February 21, 2025
The antifibrotic potential of transglutaminase 2 inhibition beyond TGFβ1 release in human kidney tissue and isolated cell culturesJudit Prat-Duran, Camilla Merrild, Nina Juste, et al.
European Journal of Pharmacology|April 12, 2025
Osthole improves erectile function by increasing endogenous H<sub>2</sub>S productionElif Alan-Albayrak, Estéfano Pinilla, Simon Comerma-Steffensen, et al.
British Journal of Pharmacology|November 26, 2015
Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteriesMorten Engholm, Estéfano Pinilla, Susie Mogensen, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2020
Transglutaminase 2 Inhibitor LDN 27219 Age-Dependently Lowers Blood Pressure and Improves Endothelium-Dependent Vasodilation in Resistance ArteriesEstéfano Pinilla, Simon Comerma-Steffensen, Judit Prat-Duran, et al.
Clinical Science (London, England : 1979)|December 12, 2024
Sex-mediated effects of transglutaminase 2 inhibition on endothelial function in human resistance arteries from diabetic and non-diabetic patientsKhatera Saii, Judit Prat-Duran, Ulf Simonsen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|December 11, 2020
Transglutaminase 2 as a novel target in chronic kidney disease - Methods, mechanisms and pharmacological inhibitionJudit Prat-Duran, Estéfano Pinilla, Rikke Nørregaard, et al.
International Journal of Molecular Sciences|May 13, 2023
Sex-Dependent Impairment of Endothelium-Dependent Relaxation in Aorta of Mice with Overexpression of Hyaluronan in Tunica MediaKaren Axelgaard Lorentzen, Raquel Hernanz, Estéfano Pinilla, et al.
The Journal of Sexual Medicine|March 24, 2022
Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db MiceSimon Comerma-Steffensen, Judit Prat-Duran, Susie Mogensen, et al.
The Journal of Sexual Medicine|April 14, 2023
Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db MiceSimon Comerma-Steffensen, Judit Prat-Duran, Susie Mogensen, et al.
International Journal of Molecular Sciences|June 26, 2025
Renal and Vascular Effects of the Allosteric Transglutaminase 2 Modulator LDN-27219 in One-Kidney DOCA-Salt MiceIan Mees, Judit Prat-Duran, Simon Comerma-Steffensen, et al.
Life Sciences|February 21, 2025
The antifibrotic potential of transglutaminase 2 inhibition beyond TGFβ1 release in human kidney tissue and isolated cell culturesJudit Prat-Duran, Camilla Merrild, Nina Juste, et al.
European Journal of Pharmacology|April 12, 2025
Osthole improves erectile function by increasing endogenous H<sub>2</sub>S productionElif Alan-Albayrak, Estéfano Pinilla, Simon Comerma-Steffensen, et al.
British Journal of Pharmacology|November 26, 2015
Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteriesMorten Engholm, Estéfano Pinilla, Susie Mogensen, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2020
Transglutaminase 2 Inhibitor LDN 27219 Age-Dependently Lowers Blood Pressure and Improves Endothelium-Dependent Vasodilation in Resistance ArteriesEstéfano Pinilla, Simon Comerma-Steffensen, Judit Prat-Duran, et al.
Clinical Science (London, England : 1979)|December 12, 2024
Sex-mediated effects of transglutaminase 2 inhibition on endothelial function in human resistance arteries from diabetic and non-diabetic patientsKhatera Saii, Judit Prat-Duran, Ulf Simonsen, et al.
Pageof 2